8-K: Cosmos Health Appoints Theodoros Karkantzos to Board

Cosmos Health Inc. announced the immediate appointment of Theodoros C. Karkantzos to its Board of Directors and Nominating and Corporate Governance Committee.

Summary

• Cosmos Health Inc. appointed Theodoros C. Karkantzos to its Board of Directors, effective September 30, 2025.
• Mr. Karkantzos was also appointed as a member of the Nominating and Corporate Governance Committee.
• He brings over 15 years of experience in investment and business development, including co-founding Blue Dot Digital Agency.
• His expertise spans finance, strategy, private equity, and asset management, with a focus on real estate, healthcare, equities, and hospitality.
• Mr. Karkantzos holds an MPhil in Real Estate Finance from the University of Cambridge and a BSc in Management from the University of Warwick.
• He will receive an annual cash fee of $10,000 for Board participation and $5,000 for his committee role, plus equity compensation under the 2025 Omnibus Incentive Plan.
• From July 1, 2024, to August 28, 2025, Mr. Karkantzos provided consulting services to the Company through C Capital Media Ltd. without cash or equity compensation.

Sentiment

Score: 7

Explanation: The appointment of a highly qualified individual with extensive experience in investment and business development is a positive step for corporate governance and strategic oversight, indicating a strengthening of the board.

Positives

• The appointment of Theodoros C. Karkantzos, with over 15 years of experience in investment and business development, strengthens the Board's expertise.
• His background in finance, strategy, private equity, and asset management, particularly in healthcare, aligns well with the company's operations.
• His academic achievements, including an MPhil from Cambridge with distinction and awards, indicate a high level of analytical and strategic capability.
• His appointment to the Nominating and Corporate Governance Committee enhances the company's governance structure.

Future Outlook

The initial term for Mr. Karkantzos as a director is set to expire on the date of the Company's 2026 annual meeting of stockholders.

Industry Context

The appointment of a director with strong financial and strategic expertise is a common practice for publicly traded companies seeking to enhance their corporate governance and strategic oversight, particularly in dynamic sectors like healthcare.

Management Changes

Corporate Governance

Related Party Transactions

• Theodoros C. Karkantzos, in his capacity as director of C Capital Media Ltd., provided consulting services to the Company from July 1, 2024, to August 28, 2025, for which he received no cash or equity compensation.

Stakeholder Impact

• Shareholders: Benefit from enhanced board expertise and corporate governance, potentially leading to better strategic decisions and oversight.
• Management: Gains a new board member with significant experience in finance and strategy, offering valuable guidance and oversight.

Next Steps

• Mr. Karkantzos's initial term as a director will expire at the Company's 2026 annual meeting of stockholders.

Key Dates

Recommendation

The appointment of Theodoros C. Karkantzos, a highly qualified individual with strong financial and strategic expertise, strengthens the company's corporate governance and strategic capabilities. While a positive development, this event alone is not expected to significantly alter the company's immediate financial trajectory or warrant a change from a 'hold' position, but it contributes to long-term stability and oversight.

Keywords

Cosmos Health, Board Appointment, Director, Corporate Governance, Healthcare, Investment, Business Development, NASDAQ